Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma

Chen, Hua-Dong; Huang, Chen-Song; Xu, Qiong-Cong; Li, Fuxi; Huang, Xi-Tai; Wang, Jie-Qin; Li, Shi-Jin; Zhao, Wei; Yin, Xiao-Yu

doi:10.7150/ijbs.39779



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2020; 16(7):1207-1217. doi:10.7150/ijbs.39779 This issue Cite

Research Paper

Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma

Hua-Dong Chen^1,2#, Chen-Song Huang^1#, Qiong-Cong Xu^1#, Fuxi Li^3,4, Xi-Tai Huang¹, Jie-Qin Wang¹, Shi-Jin Li¹, Wei Zhao^3,4✉, Xiao-Yu Yin^1✉

1. Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
2. Department of Pediatric Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
3. RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China
4. Key Laboratory of Stem Cells and Tissue Engineering (Sun Yat-Sen University), Ministry of Education, Guangzhou 510080, China
^#These authors contribute equally to this study.

Citation:

Chen HD, Huang CS, Xu QC, Li F, Huang XT, Wang JQ, Li SJ, Zhao W, Yin XY. Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma. Int J Biol Sci 2020; 16(7):1207-1217. doi:10.7150/ijbs.39779. https://www.ijbs.com/v16p1207.htm

Other styles

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a lethal malignancy with high mortality and lack of effective therapeutic targets. Here, we found that expression of cyclin-dependent kinase 7 (CDK7) was significantly associated with higher tumor grade and worse prognosis in 96 ICC specimens. Depletion of CDK7 significantly inhibited cell growth, induced a G2/M cell cycle arrest, and reduced the migratory and invasive potential in ICC cells. Subsequent experiments demonstrated that ICC cells were highly sensitive to the CDK7 inhibitor THZ1. A low concentration of THZ1 markedly inhibited cell growth, cell cycle, migration, and invasion in ICC cell lines. RNA-sequencing (RNA-seq) analysis revealed that THZ1 treatment decreased the levels of massive oncogene transcripts, particularly those associated with cell cycle and cell migration. Quantitative reverse transcriptase PCR (qRT-PCR) analysis confirmed that transcription of oncogenes involved in cell cycle regulation (AURKA, AURKB, CDC25B, CDK1, CCNA2, and MKI67) and the c-Met pathway (c-Met, AKT1, PTK2, CRK, PDPK1, and ARF6) was selectively repressed by THZ1. In addition, THZ1 exhibited significant anti-tumor activity in a patient-derived xenograft (PDX) model of ICC, without causing detectable side effects.

Keywords: Intrahepatic cholangiocarcinoma, Cyclin-dependent Kinase 7, THZ1, Cell cycle, c-Met

Citation styles

APA

Chen, H.D., Huang, C.S., Xu, Q.C., Li, F., Huang, X.T., Wang, J.Q., Li, S.J., Zhao, W., Yin, X.Y. (2020). Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma. International Journal of Biological Sciences, 16(7), 1207-1217. https://doi.org/10.7150/ijbs.39779.

ACS

Chen, H.D.; Huang, C.S.; Xu, Q.C.; Li, F.; Huang, X.T.; Wang, J.Q.; Li, S.J.; Zhao, W.; Yin, X.Y. Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma. Int. J. Biol. Sci. 2020, 16 (7), 1207-1217. DOI: 10.7150/ijbs.39779.

NLM

CSE

Chen HD, Huang CS, Xu QC, Li F, Huang XT, Wang JQ, Li SJ, Zhao W, Yin XY. 2020. Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma. Int J Biol Sci. 16(7):1207-1217.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.